Page de résultat 12 pour Secteur : Soins de santé Industrie : Biotechnologie Marché boursier - Cotations et cours
Liste de toutes les actions et titres avec cours, capitalisations boursières, ratios P/E et BPA
Tous les pays
- {{country.name}}
- Tous les pays
- États-Unis (1012)
- Australie (58)
- L'Autriche (16)
- Belgique (7)
- Brésil (16)
- Canada (83)
- Chine (92)
- Danemark (6)
- Finlande (4)
- France (41)
- Allemagne (738)
- Hong Kong (46)
- Inde (19)
- Irlande (1)
- Israël (19)
- Italie (4)
- Japon (37)
- Mexique (28)
- Pays-Bas (3)
- Nouvelle-Zélande (1)
- Norvège (14)
- Pologne (9)
- Russie (2)
- Corée du Sud (12)
- Espagne (4)
- Suède (70)
- Suisse (11)
- Taïwan (67)
- Thaïlande (2)
- Turquie (1)
- Royaume-Uni (69)
Tous marchés
- {{item.name}}
- Tous marchés
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Soins de santé (2608)
- {{item.name}}
- Tous secteur
- Soins de santé (2608)
Biotechnologie (2608)
- {{item.name}}
- Toutes les industries
- Biotechnologie (2608)
- Fabricants de médicaments - Général (265)
- Fabricants de médicaments - de spécialité et génériques (1632)
- Plans de soins de santé (57)
- Établissements de soins médicaux (554)
- Détaillants Pharmaceutiques (155)
- Services d'information sur la santé (419)
- Dispositifs médicaux (916)
- Instruments médicaux et des fournitures (501)
- Diagnostiques et Recherche (429)
- Distribution médicale (138)
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Vaxcyte, Inc. 5VA.F | $29.4 32.14 USD |
+1.38
|
$3.79B 4.15B USD | $100 109.31 USD | $29.4 32.14 USD | $29.4 32.14 USD | $3.79B 4.15B USD | 0 | -$3.4 -3.7 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Cytokinetics, Incorporated KK3A.F | $31 33.89 USD |
+0.65
|
$3.7B 4.05B USD | $150 163.97 USD | $31 33.89 USD | $31 33.89 USD | $3.7B 4.05B USD | 0 | -$4.51 -4.9 USD | |
| Krystal Biotech, Inc. 4KB.SG | $126.9 138.72 USD |
-0.78
|
$3.67B 4.01B USD | $0 0 USD | $126.9 138.72 USD | $126.9 138.72 USD | $3.67B 4.01B USD | 35.64 | $3.56 3.89 USD | |
| Krystal Biotech, Inc. 4KB.F | $126.75 138.55 USD |
+1.08
|
$3.66B 4B USD | $114 124.62 USD | $126.75 138.55 USD | $126.75 138.55 USD | $3.66B 4B USD | 35.70 | $3.55 3.88 USD | |
| Camurus AB (publ) 7CA.F | $60.65 66.3 USD |
+1.34
|
$3.61B 3.94B USD | $43 47 USD | $60.65 66.3 USD | $60.65 66.3 USD | $3.61B 3.94B USD | 73.96 | $0.82 0.9 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Akero Therapeutics, Inc. 0K4.F | $44.33 48.46 USD |
+2.36
|
$3.57B 3.9B USD | $125 136.64 USD | $44.33 48.46 USD | $44.33 48.46 USD | $3.57B 3.9B USD | 0 | -$3.2 -3.4 USD | |
| Genscript Biotech Corporation G51.F | $1.6 1.75 USD |
+0.28
|
$3.49B 3.82B USD | $2.77K 3.03K USD | $1.6 1.75 USD | $1.6 1.75 USD | $3.49B 3.82B USD | 0 | -$0.07 -0.07 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Merus N.V. 2GH.F | $46 50.28 USD |
+1.77
|
$3.43B 3.75B USD | $106 115.87 USD | $46 50.28 USD | $46 50.28 USD | $3.43B 3.75B USD | 0 | -$3.55 -3.8 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Ember Therapeutics EMBT | $0.4 — |
+399852
|
$3.71B — | $3.2K — | $0.0001 — | $0.0001 — | $3.71B — | 0 | $0 — | |
| Zai Lab Limited 1ZL.F | $28.6 31.26 USD |
-2.72
|
$3.31B 3.62B USD | $230 251.42 USD | $28.6 31.26 USD | $28.6 31.26 USD | $3.31B 3.62B USD | 0 | -$2.13 -2.3 USD | |
| SpringWorks Therapeutics SWTX | $46.99 — |
0
|
$3.54B — | $0 — | $0 — | $0 — | $3.54B — | 0 | $0 — | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $26.4 28.86 USD |
+1.54
|
$3.23B 3.53B USD | $115 125.71 USD | $26.4 28.86 USD | $26.4 28.86 USD | $3.23B 3.53B USD | 0 | -$4.97 -5.4 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.7 20.44 USD |
+2.72
|
$3.13B 3.42B USD | $100 109.31 USD | $18.7 20.44 USD | $18.7 20.44 USD | $3.13B 3.42B USD | 15.98 | $1.17 1.28 USD | |
| Scholar Rock Holding Corporation 2QK.F | $32.2 35.2 USD |
+3.21
|
$3.06B 3.34B USD | $150 163.97 USD | $32.2 35.2 USD | $32.2 35.2 USD | $3.06B 3.34B USD | 0 | -$2.17 -2.3 USD | |
| Viking Therapeutics, Inc. 1VT.F | $26.75 29.24 USD |
+4
|
$3B 3.28B USD | $460 502.84 USD | $26.03 28.45 USD | $26.75 29.24 USD | $3B 3.28B USD | 0 | -$0.99 -1.08 USD | |
| Zealand Pharma A/S 0NZU.IL | $375.6 55.07 USD |
-0.42
|
$22.4B 3.28B USD | $316 46.33 USD | $374.3 54.88 USD | $378.1 55.44 USD | $22.4B 3.28B USD | 0 | -$15.13 -2.2 USD | |
| Ascentage Pharma Group International 36X.F | $8.25 9.02 USD |
-4.62
|
$2.94B 3.21B USD | $174 190.21 USD | $8.25 9.02 USD | $8.3 9.07 USD | $2.94B 3.21B USD | 0 | -$0.16 -0.1 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $55.8 61 USD |
+0.9
|
$2.85B 3.12B USD | $80 87.45 USD | $55.8 61 USD | $55.8 61 USD | $2.85B 3.12B USD | 20.43 | $2.73 2.98 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Syngene International Limited SYNGENE.BO | $628.1 7.6 USD |
-0.96
|
$252.91B 3.06B USD | $12.08K 146.16 USD | $621.3 7.52 USD | $635 7.68 USD | $252.91B 3.06B USD | 50.77 | $12.37 0.15 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $48,150 36.35 USD |
-0.41
|
$3.77T 2.85B USD | $79.23K 59.8 USD | $48,000 36.23 USD | $49,350 37.25 USD | $3.77T 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $27.2 29.73 USD |
+1.49
|
$2.55B 2.79B USD | $40 43.73 USD | $27.2 29.73 USD | $27.2 29.73 USD | $2.55B 2.79B USD | 0 | -$3.48 -3.8 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| Everest Medicines Limited 6HN.F | $7.5 8.2 USD |
+2.74
|
$2.43B 2.66B USD | $60 65.59 USD | $7.25 7.93 USD | $7.5 8.2 USD | $2.43B 2.66B USD | 0 | -$0.38 -0.4 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S 0DPB.IL | $184.6 27.07 USD |
+0.75
|
$17.33B 2.54B USD | $1.52K 223.01 USD | $184.15 27 USD | $185.2 27.15 USD | $17.33B 2.54B USD | 13.10 | $14.09 2.07 USD | |
| ABL Bio Inc. 298380.KQ | $68,800 51.93 USD |
+1.18
|
$3.34T 2.52B USD | $656.58K 495.61 USD | $66,800 50.42 USD | $71,000 53.59 USD | $3.34T 2.52B USD | 0 | $0 0 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $18.35 20.06 USD |
-0.62
|
$2.24B 2.45B USD | $52 56.84 USD | $18.35 20.06 USD | $18.35 20.06 USD | $2.24B 2.45B USD | 13.01 | $1.41 1.54 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $15.98 17.47 USD |
+0.44
|
$2.21B 2.41B USD | $100 109.31 USD | $15.98 17.47 USD | $15.98 17.47 USD | $2.21B 2.41B USD | 0 | -$1.06 -1.1 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $43.6 47.66 USD |
-1.36
|
$2.16B 2.36B USD | $26 28.42 USD | $43.6 47.66 USD | $43.8 47.88 USD | $2.16B 2.36B USD | 0 | -$1.37 -1.4 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $28 30.61 USD |
+1.45
|
$2.15B 2.35B USD | $100 109.31 USD | $28 30.61 USD | $28 30.61 USD | $2.15B 2.35B USD | 0 | -$2.85 -3.1 USD | |
| Bavarian Nordic A/S BVNRY | $9.52 — |
+4.39
|
$2.35B — | $670 — | $9.49 — | $9.55 — | $2.35B — | 10.81 | $0.88 — | |
| ImmunityBio, Inc. 26CA.F | $2.42 2.65 USD |
-0.45
|
$2.14B 2.34B USD | $1K 1.09K USD | $2.42 2.65 USD | $2.42 2.65 USD | $2.14B 2.34B USD | 0 | -$0.49 -0.5 USD | |
| Galapagos NV G1LP34.SA | $8.39 1.7 USD |
+3.97
|
$11.06B 2.24B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.06B 2.24B USD | 0 | -$0.89 -0.1 USD | |
| Bavarian Nordic A/S BVNKF | $26.51 — |
0
|
$2.22B — | $108 — | $26.2 — | $26.2 — | $2.22B — | 10.04 | $2.64 — | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $105 114.78 USD |
+3.96
|
$2.03B 2.21B USD | $20 21.86 USD | $105 114.78 USD | $105 114.78 USD | $2.03B 2.21B USD | 0 | -$6.16 -6.7 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.95 17.44 USD |
+2.09
|
$2B 2.19B USD | $680 743.33 USD | $15.95 17.44 USD | $15.95 17.44 USD | $2B 2.19B USD | 0 | -$1.53 -1.6 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $33.4 36.51 USD |
+1.83
|
$1.93B 2.11B USD | $120 131.18 USD | $33.4 36.51 USD | $33.4 36.51 USD | $1.93B 2.11B USD | 3.39 | $9.84 10.76 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $5.3 1.07 USD |
-1.49
|
$10.42B 2.11B USD | $0 0 USD | $0 0 USD | $0 0 USD | $10.42B 2.11B USD | 0 | -$0.71 -0.1 USD | |
| Bavarian Nordic A/S BV3.F | $24.8 27.11 USD |
+2.35
|
$1.93B 2.11B USD | $20 21.86 USD | $24.8 27.11 USD | $24.8 27.11 USD | $1.93B 2.11B USD | 11.02 | $2.25 2.46 USD | |
| Denali Therapeutics Inc. 4DN.MU | $13.02 14.23 USD |
+3.09
|
$1.89B 2.07B USD | $0 0 USD | $13.02 14.23 USD | $13.02 14.23 USD | $1.89B 2.07B USD | 0 | -$2.28 -2.4 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.68 13.86 USD |
0
|
$1.84B 2.01B USD | $230 251.42 USD | $12.68 13.86 USD | $12.68 13.86 USD | $1.84B 2.01B USD | 0 | -$2.28 -2.4 USD | |
| BB Biotech AG BBZA.F | $33.65 36.78 USD |
+0.45
|
$1.84B 2.01B USD | $420 459.12 USD | $33.5 36.62 USD | $33.65 36.78 USD | $1.84B 2.01B USD | 0 | -$8.35 -9.1 USD | |
| Veracyte, Inc. 12V.F | $23.2 25.36 USD |
+1.75
|
$1.82B 1.99B USD | $250 273.28 USD | $23.2 25.36 USD | $23.2 25.36 USD | $1.82B 1.99B USD | 64.44 | $0.36 0.39 USD | |
| Genus GENSF | $26.01 — |
0
|
$1.97B — | $100 — | $26.01 — | $26.01 — | $1.97B — | 0 | -$0.08 — | |
| Galapagos GLPGF | $28.63 — |
0
|
$1.96B — | $190 — | $26.2 — | $26.2 — | $1.96B — | 0 | -$3.2 — | |
| Vericel Corporation ATQP.F | $35 38.26 USD |
0
|
$1.76B 1.93B USD | $3 3.28 USD | $35 38.26 USD | $35 38.26 USD | $1.76B 1.93B USD | 700.00 | $0.05 0.05 USD | |
| Galapagos NV GLPG.VI | $26.18 28.62 USD |
+1.47
|
$1.73B 1.89B USD | $0 0 USD | $26.08 28.51 USD | $26.18 28.62 USD | $1.73B 1.89B USD | 0 | -$2.73 -2.9 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.74 1.9 USD |
+3.08
|
$1.7B 1.86B USD | $15K 16.4K USD | $1.71 1.87 USD | $1.74 1.9 USD | $1.7B 1.86B USD | 0 | -$0.19 -0.2 USD | |
| Galapagos NV GXEA.F | $25.8 28.2 USD |
+3.2
|
$1.7B 1.86B USD | $2 2.19 USD | $25.8 28.2 USD | $25.8 28.2 USD | $1.7B 1.86B USD | 0 | -$2.73 -2.9 USD | |
| Galapagos NV GXE.F | $25.76 28.16 USD |
-0.54
|
$1.7B 1.86B USD | $1K 1.09K USD | $25.76 28.16 USD | $25.76 28.16 USD | $1.7B 1.86B USD | 0 | -$2.73 -2.9 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $19.3 21.1 USD |
-0.52
|
$1.69B 1.85B USD | $150 163.97 USD | $19.3 21.1 USD | $19.3 21.1 USD | $1.69B 1.85B USD | 0 | -$3.11 -3.3 USD | |
| BioArctic AB (publ) 0RV2.IL | $187.9 18.34 USD |
+0.86
|
$18.8B 1.83B USD | $228 22.26 USD | $187.9 18.34 USD | $189 18.45 USD | $18.8B 1.83B USD | 61.20 | $3.07 0.3 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| IDEAYA Biosciences, Inc. 30J.SG | $18.9 20.66 USD |
-0.53
|
$1.66B 1.81B USD | $0 0 USD | $18.9 20.66 USD | $18.9 20.66 USD | $1.66B 1.81B USD | 0 | -$3.11 -3.3 USD | |
| Centessa Pharmaceuticals plc 260.F | $12.3 13.45 USD |
+6.03
|
$1.64B 1.8B USD | $0 0 USD | $12.3 13.45 USD | $12.3 13.45 USD | $1.64B 1.8B USD | 0 | -$1.66 -1.8 USD | |
| Genus plc GBE.F | $25 27.33 USD |
-1.57
|
$1.64B 1.8B USD | $1.02K 1.11K USD | $25 27.33 USD | $25 27.33 USD | $1.64B 1.8B USD | 0 | -$0.07 -0.07 USD | |
| Amicus Therapeutics, Inc. AM6.F | $5.3 5.79 USD |
-1.85
|
$1.63B 1.78B USD | $1.11K 1.21K USD | $5.3 5.79 USD | $5.3 5.79 USD | $1.63B 1.78B USD | 0 | -$0.08 -0.08 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Sarepta Therapeutics, Inc. AB3A.F | $16.15 17.65 USD |
-1.04
|
$1.59B 1.73B USD | $34 37.17 USD | $16.15 17.65 USD | $16.15 17.65 USD | $1.59B 1.73B USD | 0 | -$2.25 -2.4 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $7.48 8.18 USD |
-1.58
|
$1.57B 1.71B USD | $1.1K 1.2K USD | $7.48 8.18 USD | $7.48 8.18 USD | $1.57B 1.71B USD | 0 | -$0.22 -0.2 USD | |
| Adaptive Biotechnologies Corporation 1HM.MU | $10.16 11.1 USD |
+0.79
|
$1.54B 1.69B USD | $0 0 USD | $10.16 11.1 USD | $10.16 11.1 USD | $1.54B 1.69B USD | 0 | -$0.81 -0.8 USD | |
| Adaptive Biotechnologies Corporation 1HM.F | $10.16 11.1 USD |
+1.67
|
$1.54B 1.69B USD | $10 10.93 USD | $10.16 11.1 USD | $10.16 11.1 USD | $1.54B 1.69B USD | 0 | -$0.81 -0.8 USD | |
| Pharma Mar PHMMF | $92.57 — |
0
|
$1.66B — | $100 — | $96.2 — | $96.2 — | $1.66B — | 70.12 | $1.32 — | |
| BioArctic AB (publ) B9A.F | $16.79 18.35 USD |
+3.64
|
$1.51B 1.65B USD | $500 546.57 USD | $16.79 18.35 USD | $16.79 18.35 USD | $1.51B 1.65B USD | 18.45 | $0.91 0.99 USD | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.45B 1.65B USD | 0 | $0 0 USD | |
| Immunocore Holdings plc 6YG.F | $29.8 32.58 USD |
-1.32
|
$1.5B 1.64B USD | $10 10.93 USD | $29.8 32.58 USD | $29.8 32.58 USD | $1.5B 1.64B USD | 0 | -$0.38 -0.4 USD | |
| Immunocore Holdings plc 6YG.MU | $29.8 32.58 USD |
+0.68
|
$1.49B 1.63B USD | $0 0 USD | $29.8 32.58 USD | $29.8 32.58 USD | $1.49B 1.63B USD | 0 | -$1.32 -1.4 USD | |
| Pharma Mar, S.A. 0RC6.IL | $82 89.64 USD |
+0.4
|
$1.48B 1.62B USD | $37 40.45 USD | $82 89.64 USD | $82.5 90.18 USD | $1.48B 1.62B USD | 73.87 | $1.11 1.21 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $9.28 10.14 USD |
+1.58
|
$1.48B 1.62B USD | $80 87.45 USD | $9.28 10.14 USD | $9.28 10.14 USD | $1.48B 1.62B USD | 0 | -$0.95 -1.03 USD | |
| Pharma Mar, S.A. PMRA.F | $81.95 89.58 USD |
+0.49
|
$1.45B 1.58B USD | $50 54.66 USD | $81.95 89.58 USD | $81.95 89.58 USD | $1.45B 1.58B USD | 72.52 | $1.13 1.24 USD | |
| PeptiDream PPTDF | $12 — |
-8.95
|
$1.56B — | $63 — | $11.8 — | $11.8 — | $1.56B — | 15.38 | $0.78 — | |
| Jubilant Ingrevia Limited JUBLINGREA.BO | $807.45 9.77 USD |
-0.68
|
$127.68B 1.54B USD | $12.44K 150.53 USD | $799 9.67 USD | $821.1 9.93 USD | $127.68B 1.54B USD | 50.94 | $15.85 0.19 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $29.8 32.58 USD |
0
|
$1.4B 1.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.4B 1.53B USD | 0 | $0 0 USD | |
| Biotest Aktiengesellschaft BIO3.F | $30.2 33.01 USD |
+1.34
|
$1.4B 1.53B USD | $600 655.88 USD | $29.6 32.36 USD | $30.2 33.01 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.F | $42.2 46.13 USD |
0
|
$1.4B 1.53B USD | $30 32.79 USD | $42.2 46.13 USD | $42.2 46.13 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.2 46.13 USD |
-0.94
|
$1.4B 1.53B USD | $175 191.3 USD | $42.2 46.13 USD | $43 47 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| PeptiDream Inc. 4587.T | $1,664.5 11.24 USD |
+5.62
|
$215.74B 1.46B USD | $1.64M 11.09K USD | $1,614 10.89 USD | $1,708 11.53 USD | $215.74B 1.46B USD | 14.56 | $114.26 0.77 USD | |
| Vir Biotechnology, Inc. VIR.MX | $172 10.18 USD |
0
|
$23.78B 1.41B USD | $0 0 USD | $172 10.18 USD | $172 10.18 USD | $23.78B 1.41B USD | 0 | -$78.1 -4.6 USD | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $2.92 3.19 USD |
+2.82
|
$1.27B 1.39B USD | $4 4.37 USD | $2.92 3.19 USD | $2.92 3.19 USD | $1.27B 1.39B USD | 13.90 | $0.21 0.23 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $19.1 20.88 USD |
+1.06
|
$1.27B 1.39B USD | $36 39.35 USD | $19.1 20.88 USD | $19.1 20.88 USD | $1.27B 1.39B USD | 0 | -$2.3 -2.5 USD | |
| Mesoblast MEOBF | $0.9699 — |
0
|
$1.37B — | $1K — | $0.9699 — | $0.9699 — | $1.37B — | 0 | -$0.06 — | |
| POINT Biopharma Global PNT | $12.5 — |
0
|
$1.33B — | $0 — | $0 — | $0 — | $1.33B — | 0 | $0 — | |
| Viridian Therapeutics, Inc. 1S1.F | $14.38 15.72 USD |
+0.74
|
$1.17B 1.28B USD | $70 76.52 USD | $14.38 15.72 USD | $14.38 15.72 USD | $1.17B 1.28B USD | 0 | -$2.86 -3.1 USD | |
| Novavax, Inc. NVAX.MX | $132 7.82 USD |
+0.76
|
$21.38B 1.27B USD | $5 0.3 USD | $132 7.82 USD | $132 7.82 USD | $21.38B 1.27B USD | 2.57 | $51.23 3.03 USD | |
|
Aucune action favorite
Vous n'avez pas encore d'actions favorites, veuillez l'ajouter aux favoris pour la voir ici |
||||||||||